Inotiv

Inotiv is an active contract research organization specializing in nonclinical drug discovery, development, safety assessment, bioanalysis, DMPK studies, toxicology testing, analytical chemistry, cell/molecular biology support services, and the supply of critical research animal models. The company operates two main business units—Discovery & Safety Assessment and Research Models & Services—serving pharmaceutical/biotech companies as well as government and academic clients. It has grown through strategic acquisitions including Envigo to become one of the largest providers of research animal models globally. Inotiv does not develop its own drugs but enables R&D for clients across all major therapeutic areas with expertise spanning small molecules to biologics.